The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

Israa Salem; Manal Alsalahi; Inna Chervoneva; Lucy D. Aburto; Sankar Addya; Gregory R. Ott; Bruce A. Ruggeri; Massimo Cristofanilli; Sandra V. Fernandez

doi:10.1186/s13058-016-0694-4

Back

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

Journal article

Open access

Peer reviewed

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

Israa Salem, Manal Alsalahi, Inna Chervoneva, Lucy D. Aburto, Sankar Addya, Gregory R. Ott, Bruce A. Ruggeri, Massimo Cristofanilli and Sandra V. Fernandez

Breast cancer research : BCR, Vol.18(1), pp.37-37

24/03/2016

DOI: https://doi.org/10.1186/s13058-016-0694-4

PMCID: PMC4806466

PMID: 27009091

Abstract

ALK

CEP-37440

FAK1

IBC

Inflammatory breast cancer

TNBC

Triple-negative breast cancer

Files and links (1)

url

https://doi.org/10.1186/s13058-016-0694-4View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells
Creators - without role: Israa Salem - Thomas Jefferson University
Manal Alsalahi - Thomas Jefferson University
Inna Chervoneva - Thomas Jefferson University
Lucy D. Aburto - Thomas Jefferson University
Sankar Addya - Thomas Jefferson University
Gregory R. Ott - Teva Pharmaceuticals
Bruce A. Ruggeri - Teva Pharmaceuticals
Massimo Cristofanilli - Thomas Jefferson University
Sandra V. Fernandez - Thomas Jefferson University
Publication Details: Breast cancer research : BCR, Vol.18(1), pp.37-37
Publisher: BioMed Central
Grant note: ;
Identifiers: 9943721208331
Academic Unit: King Abdullah University of Science & Technology
Language: English
Resource Type: Journal article